An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

Medical University of Vienna, Department of Oncology, Vienna

Medical University of Vienna,Department of Obstetrics and Gynecology, Vienna

CHU Group Hospitalier Pitié-Salpêtrière, Service d'oncologie Médicale, Paris

Ashford Cancer Centre Research, Kurralta Park

BCRC-WA, Hollywood Private Hospital, Nedlands

Univ. Klinik für Innere Medizin, Klin. Abt. Onkologie, Graz

Clinical Research Alliance, Inc, Lake Success

Magee-Womens Hospital of UPMC, Pittsburgh

Mammazentrum HH am Krankenhaus Jerusalem, Hamburg

University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore

Inova Schar Cancer Institute, Fairfax

Universitaetsklinikum Schleswig-Holstein, Kiel

Hospital Clinico San Carlos, Madrid

Charleston Hematology Oncology Associates, Charleston

Saint Joseph / Candler SC Cancer Specialists, Hilton Head Island

Cancer Treatment Centers of America, Newnan

Memorial Healthcare System, Hollywood

Baptist Health Urgent Care Sawgrass, Sunrise

Florida Cancer Research Institute, LLC, Plantation

Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie

Alabama Oncology, Birmingham

North Mississippi Medical Center Hematology and Oncology Services, Tupelo

Norton Cancer Institute, Louisville

Hospital Universitario Virgen del Rocio, Seville

Ingalls Memorial Hospital, Harvey

Decatur Memorial Hospital Cancer Care Specialists of Central Illinois, Decatur

Sana Klinikum Offenbach GmbH - Frauenklinik, Offenbach

Washington University School of Medicine, St Louis

Great Plains Health (Callahan Cancer Center), North Platte

The University of Texas MD Anderson Cancer Center, Houston

Coastal Bend Cancer Center, Corpus Christi

Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau

Utah Cancer Specialists, Salt Lake City

Community Cancer Trials of Utah, Ogden

Ronald Reagan UCLA Medical Center, Los Angeles

Torrance Memorial Physician Network Cancer Care Associates, Redondo Beach

Emad Ibrahim, M.D., Inc., Redlands

Compassionate Care Research Group Inc., Riverside

The Oncology Institute of Hope and Innovation, Santa Ana

St. Joseph Heritage Healthcare, Fullerton

Compassionate Care Research Group Inc., Corona

Cancer Center of Santa Barbara with Sansum Clinic, Santa Barbara

Central Coast Medical Oncology Corporation, Santa Maria

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Institut Gustave Roussy, Villejuif

Providence Portland Medical Center, Portland

Good Samaritan Hospital Samaritan Pastega Regional Cancer Center, Corvallis

Central Maine Medical Center, Lewiston

Saint Barnabas Medical Center, Livingston

Jersey Shore University Medical Center, Neptune City

Rutgers Cancer Institute of New Jersey, New Brunswick

MD Anderson Cancer Center at Cooper, Voorhees Township

Sydney Adventist Hospital, Wahroonga

Medical University of Innsbruck-Department of Gynecology, Innsbruck

Uniklinikum Salzburg, Landeskrankenhaus, Univ. Klinik fur Innere Medizin III der PMU, Salzburg

Sunnybrook Research Insitute, Toronto

McGill University Health Centre, Cedars Cancer Centre, Montreal

Universitaetsklinikum Schleswig-Holstein (UKSH), Klinik fuer Gynaekologie und Geburtshilfe, Studienzentrale Gynäkologische Onkologie (SGC) Kiel, Kiel